Importantly, re-expression of KLF4 in DUB3-silenced HCC cells completely restored DUB3 expression and the sensitivity to 5-FU or cisplatin treatment (Fig. 5D, E–H). The gene discussed is USP17L2; the disease is hepatocellular carcinoma.